Oral anticoagulants

Bibliographic Information

Oral anticoagulants

edited by Leon Poller, Jack Hirsh

Arnold , Oxford University Press, 1996

Available at  / 6 libraries

Search this Book/Journal

Note

Includes index

Description and Table of Contents

Description

Warfarin and related drugs have been used for over half a century in prevention and treatment of thrombotic disorders. Only recently however has their clinical role been firmly established by randomised studies and their benefit/risk ratio improved by lower dose therapy with improvements in laboratory monitoring. 'Oral Anticoagulants' is the first comprehensive, practical survey of the subject available. An international team of recognised experts provide detailed coverage on the mode of action; clinical pharmodynamics; magnitude and sources of variability in individuals response to oral anticoagulant; methods of individualising dosing regimens; laboratory monitoring; and comparison between the different currently prescribed oral anticoagulants.

Table of Contents

Preface The history of the development of oral anticoagulant drugs Structure and mechanisms of activation of vitamin K antagonists Pharmacokinetics and drug interactions with Warfarin Laboratory monitoring of anticoagulants Proteins induced by vitamin K absence (PIVKA's) the effect of coumarins circulating clotting factors Effects of vitamin K and oral anticoagulants on human bone metabolism Human recombinant tissue factor. Development and initial studies in monitoring Warfarin The effects of oral anticoagulants on molecular markers of thrombosis Oral anticoagulants in the prevention and treatment of venous thromboembolism Atrial fibrillation and oral anticoagulants Oral anticoagulants in the secondary and primary prevention of myocardial infarction and coronary death Valvular heart disease and heart valve prosthesis Oral anticoagulants for prevention of stroke and cerebral embolism Practical dosing considerations with Warfarin and optimal therapeutic range Use of anticoagulants in pregnancy Hemorrhagic complications or oral anticoagulant therapy Oral anticoagulation therapy in paediatric patients Warfarin in the treatment of cancer Oral anticoagulants in the elderly Indications and results with combined Warfarin and antiplatelet drugs Anticoagulation in cardiomyopathy Rebound hypercoagulability after discontinuation of oral anticoagulants Index

by "Nielsen BookData"

Details

Page Top